University of Thessaly (UTH)
Εκτίμηση της in vivo δραστικότητας του κυτοχρώματος CYP1A2 με χρωματογραφικό προσδιορισμό των μεταβολιτών της καφεΐνης σε ασθενείς με χρόνια ηπατική νόσο
Abstract
dc:descriptionTraditional liver function tests give information in severe hepatocellular dysfunction. The aim of this study was to investigate whether the caffeine test may be used as a prognostic factor, for the assessment of the “functional hepatocellular mass” in patients with chronic liver disease of different etiologies and stages even in early stages of liver diseases. Methods: 340 patients with chronic liver disease and 165 healthy volunteers were included. After a refrainment from caffeine intake for a 48-hour period, a capsula containing 200mg caffeine was administered. 6h later a spot urine samples was collected. Concentrations of caffeine and its metabolites were determined in urine samples by high-performance liquid chromatography (HPLC). Results: The effects of gender, age and mass index were not taken under acount in the statistical analysis. The effects of smoking on caffeine metabolic ratio were assessed in the samples of the healthy volounteers. CYP1A2 activity had a statistically significant positive relationship with cigarette smoking. Therefore we separated the participants in two major groups according to the smoking habits. In non-smokers, CYP1A2 activity was statistically significant reduced even in mild hepatocellular dysfunction. There were statistically significant differences in CYP1A2 activity among healthy volunteers and patients with “inactive” liver disease, among patients with “active” liver disease and patients with compensated cirrhosis and among patients with compensated cirrhosis and non-compensated cirrhosis. CYP1A2 activity was not significantly affected according to the etiology of liver disease. There was statistically significant difference only in few comparisons among caffeine metabolic ratios in patients suffering from liver disease of different etiology. Conclusion: The estimation of CYP1A2 activity using caffeine clearance (spot urine sample) is a sensitive quantitative test of liver function even for early functional impairment, especially for non-smokers. Although it is essential to separate smokers and non-smokers, information obtained from the present study helps the clinician to assess the impairment of liver function and the stage of liver disease, in order to improve prognosis, treatment and the follow up of a particular patient. It is a simple, safe and not innocuous procedure yielding reliable data regarding disease severity and prognosis.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papakosta, Styliani
- Παπακώστα, Στυλιανή
Subjects
dc:subject × 19Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23237